Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

108.16 +2.18 (+2.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,006,608
Open 106.00
Bid (Size) 106.09 (100)
Ask (Size) 109.11 (100)
Prev. Close 105.98
Today's Range 105.53 - 108.67
52wk Range 53.56 - 108.81
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at immuno-oncology stocks, starting with... 
Via StockStory
Topics Artificial Intelligence
Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks
Looking back on immuno-oncology stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers. 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
+55.6%
+55.6%
1 Month
+27.7%
+27.7%
3 Month
+32.5%
+32.5%
6 Month
+77.9%
+77.9%
1 Year
+32.7%
+32.7%

More News

Read More
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
Via StockStory
Topics Economy Supply Chain
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
From Incyte
Via Business Wire
Earnings Scheduled For October 28, 2025
Via Benzinga
Exploring Incyte's Earnings Expectations
Via Benzinga
Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
The 5 Most Interesting Analyst Questions From Incyte’s Q3 Earnings Call
Via StockStory
Topics Earnings
Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
From Incyte
Via Business Wire
Incyte to Present at Upcoming Investor Conferences
From Incyte
Via Business Wire
INCY Q3 Deep Dive: Strong Product Momentum and Pipeline Reshaping Amid Strategic Refocus
Via StockStory
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms
Via Benzinga
Topics Intellectual Property
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Why Incyte (INCY) Stock Is Trading Lower Today
Via StockStory
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy
Incyte (INCY) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Incyte Falls After Hiked 2025 Outlook Misses Wall Street's Bullish Views
Via Investor's Business Daily
Topics Government
Incyte Corp (NASDAQ:INCY) Reports Strong Q3 2025 Earnings, Beating Estimates
Via Chartmill
Topics Earnings
Incyte (NASDAQ:INCY) Reports Strong Q3
Via StockStory
Topics Artificial Intelligence
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Incyte
Via Business Wire

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 108.16
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 24.06B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 24B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.